Seeking Alpha

Dr. John Faessel's  Instablog

Dr. John Faessel
Send Message
Dr. John L. Faessel is a seasoned and respected Wall Street professional with industry-wide recognition for expertise in market strategy and analysis. He is widely recognized for his insights in public companies. For over 20-years Dr. Faessel’s ON THE MARKET reports have been widely distributed... More
  • A 2011 Best Idea from my Top Picks*  0 comments
    Dec 29, 2010 6:43 AM | about stocks: RCPI

    Dr. John L. Faessel

    ON THE MARKET

    Commentary and Insights

    Dr.Faessel@onthemar.com

     

    A 2011 Best Idea from my Top Picks*

     

    Star Scientific Inc. (CIGX) $2.08 Nasdaq

     

    (CIGX) is one of the top (if not "the" top) stock speculations I have ever come across. For starters insiders and 5% holders recently bought an "additional" $14 million worth of shares plus warrants (with a 6-month lock-up too I believe.) The “connect the dots” rational could make this (CIGX) one for the ages. The story goes (and I'm a believer because I have tried the CigRx™ product) - that the company is now marketing CigRx™ an over-the-counter (no Dr. prescription required) Tic-Tac type non-nicotine nutraceutical, made from natural ingredients that temporarily reduces the urge to smoke., Imagine the market. And you can purchase it very simply online; www.cigrx.com Tobacco use will kill 6.5 million people in 2010 from cancer, heart disease, emphysema and other diseases. Gross cigarette sales are $325 billion a year.

     

    That's just a part of the story; There are several other looming, potentially hugely market moving dimensions to (CIGX) that are percolating and ready to pop, like the Roskamp studies related to a potential Alzheimer cure / treatment, plus the mega lawsuit against tobacco giant RJ Reynolds, that is being orchestrated by the powerful law firm Sidley and Austin LLP (a major patent law impresario that has lost just a couple of patent suits over their long history) that alone drove the stock to just below $6 last year. In addition to the newly announced human trials, Roskamp is working with researchers at Johns Hopkins School of Medicine for other medical applications of the compound. I believe that we will hear more on this endeavor soon. If that’s not enough to boggle your mind, there’s even more home run potential; (CIGX) has applied to the FDA for approval to advertise its proprietary BDL (Below Detectable Levels) technology that can lower the nitrosamine (the harmful part of tobacco complex) content to the zero level. Importantly, they are the one and only company that can do that. Imagine if they get FDA approval on that one? “Big Tobacco” will have to license the BDL technology ASAP I believe. Now add in the possibility of a buyout. Big Pharma is always in search of significant new revenue sources and with the fact that smoking issues are so huge worldwide; wouldn't some enterprising Pharma company become involved with either a type of licensing agreement or even a buyout?  Perhaps, Big Tobacco will also have an interest I’m sure. Institutional ownership continues to grow.

     

    Currently 78 financial institutions hold about 24% of the shares. And of note, (CIGX) has $6.1 million in cash. Market-cap $241 million. Website: http://www.starscientific.com  

    To watch the CigRx™ infomercial:  http://www.cigrx.com

     

    I own (CIGX) shares.

     

    * For my Best Ideas for 2011 request: Dr.Faessel@onthemar.com



    Disclosure: I am long CIGX.
Back To Dr. John Faessel's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.